Conatus Pharmaceuticals Reports First Quarter 2018 Financial Results and Program Updates
May 02, 2018 20:05 pm UTC| Business
SAN DIEGO, May 02, 2018 -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, today announced financial results for the first...
Recro Pharma Announces Commercial Team Additions
May 02, 2018 20:05 pm UTC| Business
MALVERN, Pa., May 02, 2018 -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today announced the...
James River Announces First Quarter 2018 Results
May 02, 2018 20:05 pm UTC| Business
First Quarter 2018 Net Income of $15.6 million -- $0.52 per diluted share, and Adjusted Net Operating Income of $16.6 million -- $0.55 per diluted share Three month annualized Adjusted Net Operating Return on Average...
Green Bancorp, Inc. to Present at the 2018 Gulf South Bank Conference
May 02, 2018 20:05 pm UTC| Business
HOUSTON, May 02, 2018 -- Green Bancorp, Inc. (NASDAQ:GNBC), the bank holding company that operates Green Bank, N.A., today announced Geoff Greenwade, President of the Company and Chief Executive Officer of the Bank,...
Pacific Ethanol to Release First Quarter 2018 Results
May 02, 2018 20:05 pm UTC| Business
SACRAMENTO, Calif., May 02, 2018 -- Pacific Ethanol, Inc. (NASDAQ:PEIX), a leading producer and marketer of low-carbon renewable fuels and high-quality alcohol products in the United States, announced it will release...
TTM Technologies, Inc. Reports Fiscal First Quarter 2018 Results
May 02, 2018 20:05 pm UTC| Business
COSTA MESA, Calif., May 02, 2018 -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (“PCB”) manufacturer, today reported results for the first quarter of fiscal 2018, which ended April 2nd,...
Ovid Therapeutics to Present at Deutsche Bank’s 43rd Annual Health Care Conference on May 9, 2018
May 02, 2018 20:05 pm UTC| Business
NEW YORK, May 02, 2018 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological disorders, today announced that...